373 related articles for article (PubMed ID: 22160727)
21. FGFR4 prevents hyperlipidemia and insulin resistance but underlies high-fat diet induced fatty liver.
Huang X; Yang C; Luo Y; Jin C; Wang F; McKeehan WL
Diabetes; 2007 Oct; 56(10):2501-10. PubMed ID: 17664243
[TBL] [Abstract][Full Text] [Related]
22. Growth hormone improves body composition, fasting blood glucose, glucose tolerance and liver triacylglycerol in a mouse model of diet-induced obesity and type 2 diabetes.
List EO; Palmer AJ; Berryman DE; Bower B; Kelder B; Kopchick JJ
Diabetologia; 2009 Aug; 52(8):1647-55. PubMed ID: 19468705
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-185-5p inhibits hepatic gluconeogenesis and reduces fasting blood glucose levels by suppressing G6Pase.
Zheng H; Wan J; Shan Y; Song X; Jin J; Su Q; Chen S; Lu X; Yang J; Li Q; Song Y; Li B
Theranostics; 2021; 11(16):7829-7843. PubMed ID: 34335967
[No Abstract] [Full Text] [Related]
24. Gdf11 gene transfer prevents high fat diet-induced obesity and improves metabolic homeostasis in obese and STZ-induced diabetic mice.
Lu B; Zhong J; Pan J; Yuan X; Ren M; Jiang L; Yang Y; Zhang G; Liu D; Zhang C
J Transl Med; 2019 Dec; 17(1):422. PubMed ID: 31847906
[TBL] [Abstract][Full Text] [Related]
25. Skeletal muscle-specific Cre recombinase expression, controlled by the human α-skeletal actin promoter, improves glucose tolerance in mice fed a high-fat diet.
Al Batran R; Gopal K; Martin MD; Ho KL; Almutairi M; Aburasayn H; Eaton F; Campbell JE; Ussher JR
Diabetologia; 2018 Aug; 61(8):1849-1855. PubMed ID: 29858650
[TBL] [Abstract][Full Text] [Related]
26. Ipragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight Reduction.
Komiya C; Tsuchiya K; Shiba K; Miyachi Y; Furuke S; Shimazu N; Yamaguchi S; Kanno K; Ogawa Y
PLoS One; 2016; 11(3):e0151511. PubMed ID: 26977813
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of miR-153, an IL-1β-responsive miRNA, prevents beta cell failure and inflammation-associated diabetes.
Sun Y; Zhou S; Shi Y; Zhou Y; Zhang Y; Liu K; Zhu Y; Han X
Metabolism; 2020 Oct; 111():154335. PubMed ID: 32795559
[TBL] [Abstract][Full Text] [Related]
28. MiR-495 regulates macrophage M1/M2 polarization and insulin resistance in high-fat diet-fed mice via targeting FTO.
Hu F; Tong J; Deng B; Zheng J; Lu C
Pflugers Arch; 2019 Dec; 471(11-12):1529-1537. PubMed ID: 31709454
[TBL] [Abstract][Full Text] [Related]
29. lncRNA MEG3 promotes hepatic insulin resistance by serving as a competing endogenous RNA of miR-214 to regulate ATF4 expression.
Zhu X; Li H; Wu Y; Zhou J; Yang G; Wang W
Int J Mol Med; 2019 Jan; 43(1):345-357. PubMed ID: 30431065
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-21 regulates hepatic glucose metabolism by targeting FOXO1.
Luo A; Yan H; Liang J; Du C; Zhao X; Sun L; Chen Y
Gene; 2017 Sep; 627():194-201. PubMed ID: 28627440
[TBL] [Abstract][Full Text] [Related]
31. Nervous System Expression of PPARγ and Mutant PPARγ Has Profound Effects on Metabolic Regulation and Brain Development.
Stump M; Guo DF; Lu KT; Mukohda M; Cassell MD; Norris AW; Rahmouni K; Sigmund CD
Endocrinology; 2016 Nov; 157(11):4266-4275. PubMed ID: 27575030
[TBL] [Abstract][Full Text] [Related]
32. Partial leptin deficiency confers resistance to diet-induced obesity in mice.
Zhao S; Li N; Zhu Y; Straub L; Zhang Z; Wang MY; Zhu Q; Kusminski CM; Elmquist JK; Scherer PE
Mol Metab; 2020 Jul; 37():100995. PubMed ID: 32289482
[TBL] [Abstract][Full Text] [Related]
33. Opposing effects of reduced kidney mass on liver and skeletal muscle insulin sensitivity in obese mice.
Chin SH; Item F; Wueest S; Zhou Z; Wiedemann MS; Gai Z; Schoenle EJ; Kullak-Ublick GA; Al-Hasani H; Konrad D
Diabetes; 2015 Apr; 64(4):1131-41. PubMed ID: 25325737
[TBL] [Abstract][Full Text] [Related]
34. Impact of transgenic overexpression of SH2-containing inositol 5'-phosphatase 2 on glucose metabolism and insulin signaling in mice.
Kagawa S; Soeda Y; Ishihara H; Oya T; Sasahara M; Yaguchi S; Oshita R; Wada T; Tsuneki H; Sasaoka T
Endocrinology; 2008 Feb; 149(2):642-50. PubMed ID: 18039790
[TBL] [Abstract][Full Text] [Related]
35. High level overexpression of glucose transporter-4 driven by an adipose-specific promoter is maintained in transgenic mice on a high fat diet, but does not prevent impaired glucose tolerance.
Gnudi L; Tozzo E; Shepherd PR; Bliss JL; Kahn BB
Endocrinology; 1995 Mar; 136(3):995-1002. PubMed ID: 7867610
[TBL] [Abstract][Full Text] [Related]
36.
Lee HA; Cho JH; Afinanisa Q; An GH; Han JG; Kang HJ; Choi SH; Seong HA
Nutrients; 2020 Oct; 12(11):. PubMed ID: 33142995
[No Abstract] [Full Text] [Related]
37. Interferon regulatory factor 7 deficiency prevents diet-induced obesity and insulin resistance.
Wang XA; Zhang R; Zhang S; Deng S; Jiang D; Zhong J; Yang L; Wang T; Hong S; Guo S; She ZG; Zhang XD; Li H
Am J Physiol Endocrinol Metab; 2013 Aug; 305(4):E485-95. PubMed ID: 23695216
[TBL] [Abstract][Full Text] [Related]
38. Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism.
Jordan SD; Krüger M; Willmes DM; Redemann N; Wunderlich FT; Brönneke HS; Merkwirth C; Kashkar H; Olkkonen VM; Böttger T; Braun T; Seibler J; Brüning JC
Nat Cell Biol; 2011 Apr; 13(4):434-46. PubMed ID: 21441927
[TBL] [Abstract][Full Text] [Related]
39. Endospanin1 affects oppositely body weight regulation and glucose homeostasis by differentially regulating central leptin signaling.
Vauthier V; Roujeau C; Chen P; Sarkis C; Migrenne S; Hosoi T; Ozawa K; Rouillé Y; Foretz M; Mallet J; Launay JM; Magnan C; Jockers R; Dam J
Mol Metab; 2017 Jan; 6(1):159-172. PubMed ID: 28123946
[TBL] [Abstract][Full Text] [Related]
40. p53-upregulated-modulator-of-apoptosis (PUMA) deficiency affects food intake but does not impact on body weight or glucose homeostasis in diet-induced obesity.
Litwak SA; Loh K; Stanley WJ; Pappas EG; Wali JA; Selck C; Strasser A; Thomas HE; Gurzov EN
Sci Rep; 2016 Apr; 6():23802. PubMed ID: 27033313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
